Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Deloitte
Medtronic
McKinsey
Merck
Farmers Insurance
QuintilesIMS
UBS
Harvard Business School

Generated: May 25, 2018

DrugPatentWatch Database Preview

PROPAFENONE HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Propafenone Hydrochloride, and when can generic versions of Propafenone Hydrochloride launch?

Propafenone Hydrochloride is a drug marketed by Glenmark Pharms Ltd, Mylan Pharms Inc, Par Pharm, Watson Labs Inc, Ani Pharms Inc, Aurobindo Pharma Ltd, Nesher Pharms, Sun Pharm Industries, Vintage Pharms, and Watson Labs. and is included in ten NDAs.

The generic ingredient in PROPAFENONE HYDROCHLORIDE is propafenone hydrochloride. There are eleven drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the propafenone hydrochloride profile page.
Drug patent expirations by year for PROPAFENONE HYDROCHLORIDE
Pharmacology for PROPAFENONE HYDROCHLORIDE
Drug ClassAntiarrhythmic
Medical Subject Heading (MeSH) Categories for PROPAFENONE HYDROCHLORIDE
Synonyms for PROPAFENONE HYDROCHLORIDE
1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenylpropan-1-one hydrochloride
1-(2-[2-Hydroxy-3-(propylamino)propoxy]phenyl)-3-phenyl-1propanone
1-[2-(2-Hydroxy-3-(propylamino)propoxy)phenyl]-3-phenyl-1-propanone hydrochloride
1-[2-[2-hydroxy-3- propoxy]phenyl]-3-phenylpropan-1-onehydrochloride
1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-1-propanone hydrochloride
1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one hydrochloride
1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one hydrochloride
1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one;hydrochloride
1-[2-[2-oxidanyl-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one hydrochloride
1-{2-[2-hydroxy-3-(propylamino)propoxy]phenyl}-3-phenylpropan-1-one hydrochloride
1-Propanone, 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-, hydrochloride
1-Propanone,1-[2-[(2R)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-, hydrochloride(9CI)
1-Propanone,1-[2-[(2S)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-, hydrochloride(1:1)
163858-56-8
183P227
2-hydroxy-3-[2-(3-phenylpropanoyl)phenoxy]-N-propylpropan-1-aminium chloride
2'-(2-Hydroxy-3-(propylamino)propoxy)-3-phenylpropiophenone hydrochloride
2'-(2-hydroxy-3-propylaminopropoxy)-3-phenylpropiophenone hydrochloride
2'-[2-Hydroxy-3-(propylamino)propoxy]-3-phenylpropiophenone Hydrochloride
34183-22-7
54063-53-5 (Parent)
A822113
AB0011670
AC-11360
AC1L1W9R
AC1Q39QV
AC1Q3DVX
ACMC-20cvw7
ACMC-20cvw9
AKOS008901409
AN-6428
Arythmol
Baxarytmon
C21H28ClNO3
CCG-39061
CHEBI:8466
CHEMBL1201063
CPD000058493
CS-2538
CTK6E5427
D00640
EINECS 251-867-9
EN300-51034
EU-0100919
Fenoprain
FT-0630579
HMS1569D19
HMS1922M16
HY-B0432A
J-019481
J10361
K-7828
KS-000000SR
KS-5030
LP00919
LS-125353
MCULE-5193630487
MFCD00079243
MLS000069682
MLS001148185
MLS002222267
MolPort-003-666-514
NCGC00094230-01
NCGC00094230-02
NCGC00094230-03
NCGC00094230-04
NCGC00094230-05
NCGC00261604-01
NSC-758640
NSC758640
Opera_ID_1835
P 4670
P2301
Pharmakon1600-01503935
Prestwick_831
Pronon
Propafenon hydrochlorid
Propafenon hydrochlorid [German]
Propafenone (hydrochloride)
Propafenone HCl
Propafenone hydrochloride (JP17/USP)
Propafenone hydrochloride [USAN:JAN]
Propafenone hydrochloride, European Pharmacopoeia (EP) Reference Standard
Propafenone hydrochloride, United States Pharmacopeia (USP) Reference Standard
Propiophenone, 2'-(2-hydroxy-3-(propylamino)propoxy)-3-phenyl-, hydrochloride
Rhythmonorm
Rythmol (TN)
Rythmol SR
Rytmonorm
SA 79
SAM002548929
SC-47004
SCHEMBL41412
SMR000058493
SPECTRUM1503935
SR-01000000192
SR-01000000192-2
ST51054219
Tox21_500919
WZ 884
XWIHRGFIPXWGEF-UHFFFAOYSA-N
Z802671518

US Patents and Regulatory Information for PROPAFENONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 075203-001 Oct 24, 2000 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 075203-002 Oct 24, 2000 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Pharms Ltd PROPAFENONE HYDROCHLORIDE propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205268-001 Sep 8, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 202445-003 May 11, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Moodys
Cantor Fitzgerald
UBS
QuintilesIMS
Daiichi Sankyo
Baxter
Deloitte
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.